Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteseraprognostics.com
CategoryBioTech
Phone801-505-0630
Emailinfo@seraprognost...
Employees
Founded2008

Offices

Salt Lake City, USA
417 Wakara Way
Suite 3510
Salt Lake City, UT, 84108
USA

People

CFO
President & COO
Board of Directors
Board of Directors
Chairman and CEO

Funding

TOTAL $35.4M
FUNDING TOTAL $35.4M
Series A, 1/2011
Catalyst Health & Technology Partners
Upstart Capital
$1.4M
Series A, 11/2011
InterWest Partners
Domain Associates
Catalyst Health & Technology Partners
Osage University Partners
Upstart Capital
$19.3M
Private Equity, 11/2012
$10.2M
Partial Close, 3/2014
$4.5M

Tags

Sera Prognostics

Sera Prognostics is a private biotechnology company developing diagnostic tests that use proprietary biomarkers that are predictive of preterm birth and other pregnancy complications. Sera was founded in 2008 and licensed its serum proteomics discovery technology and novel peptides from Brigham Young University and the University of Utah. The company has assembled a board of directors and management team with significant clinical development and women’s healthcare diagnostic experience for translating scientific innovation into commercial products that help patients and build significant corporate value. Sera is located in Salt Lake City, Utah.

Recent Milestones

Videos

Screenshots

Sources

  1. Sera Prognostics Closes $1.4 million Series A-­1 Financing (seraprognostics.com) [edit]
  2. Sera Secures $19.3 million Financing; Appoints Greg C. Critchfield, MD as Chief Executive Officer (seraprognostics.com) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
Edit This Page
Last Edited 3/19/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy